Intermittent Vacuum Therapy (IVT) in Women during Menopause
Systems: VACUMED® | VACUSTYLER AVANTGARDE® | VACUFIT® | VACUSPORT®
1. Background and Pathophysiology
Menopause is a complex transitional phase in a woman’s life. During this period, hormone levels, vascular functions, and regulation of the autonomic nervous system change. As estrogen declines, endothelial activity decreases—the inner vascular layer produces less nitric oxide (NO), an important vasodilatory signaling molecule [3–4, 6–7]. This leads to reduced perfusion, increased vascular tone, oxidative stress, and lower tissue oxygenation. Clinically, this presents as hot flashes, sleep disturbances, fatigue, pelvic floor weakness, skin changes, and concentration problems.
2. Mechanism of Intermittent Vacuum Therapy (IVT)
IVT alternates negative and normal pressure applied to the lower body (typically −20 to −70 mbar). These rhythmic pressure changes cause alternating stretch and decompression of blood vessels. The resulting ‘shear stress’ on the vessel walls triggers NO release. NO promotes vasodilation and improves flow in arteries, veins, and lymphatic vessels [1–4, 7]. At the same time, receptors influencing the autonomic nervous system are stimulated. The result is activation of the parasympathetic branch—the body’s rest system—supporting relaxation, regeneration, and balance [6, 14]. IVT thereby acts like an ‘external second heart’: it promotes venous and lymphatic return, improves oxygen delivery, and relieves tissue congestion [1–2, 8–10].
3. Therapeutic Goals of IVT in Menopause
- Improve perfusion in legs, pelvis, and brain [1–4].
- Activate the parasympathetic system to regulate stress, sleep, and circulation [6, 14].
- Support pelvic floor function and bladder control [1–4, 6].
- Reduce fatigue and lack of drive by improving energy supply [3–4, 6].
- Enhance skin and connective tissue tone through improved microcirculation [10, 16–18].
4. Typical Indications in Women during Menopause
- Hot flashes, circulatory weakness, cold hands and feet [1–2].
- Chronic fatigue, sleep problems, stress symptoms [6, 11–12, 14].
- Pelvic floor weakness, urinary incontinence, loss of libido [1–4].
- Weight gain and fluid retention [1–2, 10].
- Concentration problems (“brain fog”) [3–4, 6].
- Skin laxity, cellulite, and reduced skin elasticity [16–18].
5. Pelvic Floor and Stress Incontinence
Rhythmic pressure changes activate pelvic vasculature. This improves blood flow, promotes venous and lymphatic return, and stimulates reflex pathways between the bladder and pelvic floor [1–4, 6]. NO release also supports natural vasodilation and better muscle elasticity. This increases sensitivity and strength of the pelvic floor. IVT is therefore an ideal adjunct to active pelvic floor training—following the principle: “First circulation, then control” [3–4, 6, 10].
6. Fatigue and Autonomic Exhaustion
Many women during menopause suffer from chronic fatigue, lack of motivation, or inner restlessness—often due to sympathetic overactivity. IVT helps restore autonomic balance: it stimulates the parasympathetic system, stabilizes heart rate variability, and improves cerebral and muscular perfusion [3–4, 6, 11–12, 14]. Experience from sports and rehabilitation centers shows faster recovery and noticeable increases in energy and vitality [11–12].
7. Recommended Treatment Parameters
Parameters are adjusted individually. Start with lower negative pressures and increase stepwise as tolerated [16–18].
| Target | Pressure (mbar) | Intervals (s) | Duration | Frequency / Series |
| Vascular training | −25 → −50 | 10 / 10 | 25–30 min | 2–3× per week, 6–8 weeks [1–2, 16] |
| Pelvic floor / Incontinence | −25 → −45 | 8–12 / 8–10 | 25–30 min | 2–3× per week, 6 weeks [1–4, 16–18] |
| Fatigue / Stress | −25 → −45 | 10 / 10 | 25–30 min | 2–3× per week, 6 weeks; maintenance 1× per week [6, 11–12] |
| Skin / Edema | −20 → −40 | 7–12 / 7–10 | 25–30 min | 8–16 sessions in 3–6 weeks [10, 16–18] |
8. Metabolism and Cognitive Performance
IVT-triggered NO release improves vascular elasticity, reduces oxidative stress, and supports cellular energy metabolism. Cerebral blood flow is enhanced, which can improve concentration and mental clarity [3–4, 6]. Data from sports and rehabilitation medicine also show faster recovery and lactate clearance [11–12].
9. Skin and Connective Tissue
By improving microcirculation and lymphatic drainage, the skin is better supplied with oxygen. This can increase skin elasticity and visibly reduce cellulite or swelling [16–18].
10. Safety and Contraindications
IVT is non-invasive, painless, and generally well tolerated. It should not be used in acute thrombosis, unstable angina pectoris, inguinal or abdominal wall hernias, or during pregnancy [16–18]. Use caution in severe hypertension or immediately post-op until wounds are fully healed. Patients with risk factors such as diabetes, smoking, or dyslipidemia often benefit particularly well [1–2, 10].
11. Monitoring and Follow-Up
- Fatigue/Stress: Fatigue Severity Scale (FSS), sleep quality (PSQI), heart rate variability [11–12, 14].
- Pelvic floor: ICIQ-UI SF, pad test, patient-reported outcomes.
- Cognition: MoCA, Trail-Making Test [6].
- Perfusion: TcpO₂ measurement, ABI, walking distance [1–2, 9–10].
- Skin: Circumference measurement, photos, skin elasticity [16–18].
12. Scientific Evidence
Multiple studies demonstrate that IVT significantly improves perfusion, recovery, and oxygen delivery [1–2, 8–12]. Physiological measures and clinical observations show consistent improvements in vascular reactivity and autonomic regulation. Shear stress, NO, and baroreflex modulation clearly support the benefits of IVT [3–4, 6, 14].
13. Combination with Other Therapies
- Before pelvic floor training (“First circulation, then control”) [1–4].
- For recovery between training or rehabilitation sessions [11–12].
- Combined with relaxation or breathing training [14].
- Complementary to hormone therapy, exercise, and nutrition [1–4, 11–12, 16–18].
14. Short Description for Patients
Intermittent Vacuum Therapy (IVT) is a gentle yet effective method to improve circulation and recovery. Originally developed in space medicine, it activates circulation, metabolism, and the lymphatic system. Many women report more energy, better sleep, stronger pelvic floor function, and firmer skin [1–4, 10, 16–18].
References
- Sundby ØH, Høiseth LØ, Mathiesen I, Weedon-Fekjær H, Sundhagen JO, Hisdal J. The acute effects of lower limb intermittent negative pressure on foot macro- and microcirculation in patients with peripheral arterial disease. PLoS One. 2017;12(6):e0179001.
- Sundby ØH, Høiseth LØ, Mathiesen I, Jørgensen JJ, Weedon-Fekjær H, Hisdal J. Application of intermittent negative pressure on the lower extremity and its effect on macro- and microcirculation in the foot of healthy volunteers. Physiol Rep. 2016;4(17):e12911.
- Thijssen DHJ, Atkinson CL, Ono K, et al. Sympathetic activation, shear rate and flow-mediated dilation. J Appl Physiol (1985). 2014;116(10):1300–1307.
- Trinity JD, Groot HJ, Layec G, et al. Passive leg movement and nitric oxide-mediated vascular function. Am J Physiol Heart Circ Physiol. 2015;308(6):H672–H679.
- Hoel H, Høiseth LØ, Sandbæk G, Sundhagen JO, Mathiesen I, Hisdal J. The acute effects of different levels of intermittent negative pressure on peripheral circulation in patients with peripheral artery disease. Physiol Rep. 2019;7(9):e14241.
- Leach OK, Gifford JR, Mack GW. Rapid onset vasodilation during baroreceptor loading and unloading. Am J Physiol Regul Integr Comp Physiol. 2023;325(5):R568–R575.
- Mikhailov VM, Gurfinkel’ YI, Kudutkina MI, Ushakov BB. Investigation into microcirculation at rest and during the LBNP test. Aviakosm Ekolog Med. 2005;39(5):53–58.
- Worms J, Hoang LPA, Quester W, Stratmann B, Tschoepe D. Intermittent vacuum therapy in DFS with critical ischemia – case report. Diabetol Stoffwechsel. 2015;10(Suppl 1):P283.
- Schink J. Prospective study: Intermittent vacuum therapy in PAD stage II. Weyergans High Care AG; 2009.
- Campisi CC, Ryan M, Campisi CS, Boccardo F. Intermittent Negative Pressure Therapy in the combined treatment of peripheral lymphedema. Lymphology. 2015;48(4):197–204.
- Jansen van Rensburg A. The use of negative pressure wave treatment in athlete recovery. S Afr J Sports Med. 2017;29(1):1–7.
- Souto Maior A. Effects of intermittent negative pressure and active recovery in elite soccer players. Biomed Human Kinetics. 2020;12:59–68.
- Badrov MB, Usselman CW, Shoemaker JK. Sympathetic neural recruitment strategies: responses to severe chemoreflex and baroreflex stress. Am J Physiol Regul Integr Comp Physiol. 2015;309(2):R160–8.
- Weyergans High Care AG. IVT in Longevity und Biohacking. Clinical Evaluation Report – Internal Document. Düren; 2025.
- Weyergans High Care AG. VACUMED® Brochure: Intermittent vacuum therapy for the lower body. Cologne; 2022.
- Weyergans High Care AG. Vacustyler® Avantgarde Manual V03. Cologne; 2023-02-28.
- Weyergans High Care AG. VACUFIT® Plus Manual V02. Cologne; 2023-02-27.
- Weyergans High Care AG. IVT in Rehab and Vascular Medicine. Clinical Evaluation Report; Düren; 2024.